Cargando…

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study

OBJECTIVE: We investigated whether patients receiving selected antiretroviral combinations had a higher risk of chronic kidney disease (CKD) using traditional regression modeling and a causal approach in a large prospective cohort. PATIENTS AND METHODS: For the purpose of this study, we selected 630...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuzin, Lise, Pugliese, Pascal, Allavena, Clotilde, Rey, David, Chirouze, Catherine, Bani-Sadr, Firouzé, Cabié, André, Huleux, Thomas, Poizot-Martin, Isabelle, Cotte, Laurent, Isnard Bagnis, Corinne, Flandre, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720720/ https://www.ncbi.nlm.nih.gov/pubmed/29216208 http://dx.doi.org/10.1371/journal.pone.0187517

Ejemplares similares

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach
por: Cuzin, Lise, et al.
Publicado: (2015)

HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat’AIDS cohort
por: Hentzien, Maxime, et al.
Publicado: (2019)

Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients
por: Allavena, Clotilde, et al.
Publicado: (2018)

Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score
por: Hentzien, Maxime, et al.
Publicado: (2018)

Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection
por: Gantner, Pierre, et al.
Publicado: (2019)

Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study
por: de Boissieu, Paul, et al.
Publicado: (2016)

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
por: Virlogeux, Victor, et al.
Publicado: (2017)

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study
por: Cotte, Laurent, et al.
Publicado: (2017)

High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat’AIDS cohort
por: Lemmet, Thomas, et al.
Publicado: (2022)

Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France
por: Rojas Rojas, Teresa, et al.
Publicado: (2022)

Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat’AIDS cohort
por: Cuzin, L., et al.
Publicado: (2019)

Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015
por: Poizot‐Martin, I., et al.
Publicado: (2020)

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
por: Poizot-Martin, Isabelle, et al.
Publicado: (2015)

First-line cART regimen impacts the course of CD8(+) T-cell counts in HIV-infected patients that achieve sustained undetectable viral load.
por: Poizot-Martin, Isabelle, et al.
Publicado: (2016)

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART
por: Poizot-Martin, Isabelle, et al.
Publicado: (2016)

Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohort
por: Allavena, Clotilde, et al.
Publicado: (2014)

Hepatitis C treatment initiation in HIV-HCV coinfected patients
por: Cotte, Laurent, et al.
Publicado: (2016)

Economic impact of generic antiretrovirals in France for HIV patients’ care: a simulation between 2019 and 2023
por: Demeulemeester, Romain, et al.
Publicado: (2022)

Hepatitis C Therapy in Renal Patients: Who, How, When?
por: Isnard Bagnis, Corinne, et al.
Publicado: (2016)

Acceptability and confidence in antiretroviral generics of physicians and HIV-infected patients in France
por: Allavena, Clotilde, et al.
Publicado: (2014)

Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice
por: Gantner, Pierre, et al.
Publicado: (2016)

Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review
por: Bagnis, Corinne Isnard, et al.
Publicado: (2015)

Tolerance and durability of abacavir/lamivudine (ABC/3TC)-containing regimens: results from a large prospective French cohort
por: Cuzin, L, et al.
Publicado: (2010)

Perception of Antiretroviral Generic Medicines: One-Day Survey of HIV-Infected Patients and Their Physicians in France
por: Jacomet, Christine, et al.
Publicado: (2015)

Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV
por: Heron, Jack Edward, et al.
Publicado: (2020)

Association of Acute Interstitial Nephritis with Nivolumab in Renal Cell Carcinoma: A Case Report
por: Noto-Kadou-Kaza, Befa, et al.
Publicado: (2021)

Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial
por: Hall, Nolwenn, et al.
Publicado: (2022)

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort
por: Lions, C., et al.
Publicado: (2019)

Mindfulness and compassion training for health professionals: A qualitative study
por: Brun, Clémence, et al.
Publicado: (2023)

Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)
por: Salmon-Ceron, Dominique, et al.
Publicado: (2012)

Real-life conditions of use of sodium phosphate tablets for colon cleansing before colonoscopy
por: Hagège, Hervé, et al.
Publicado: (2015)

Determinants of Second Primary Cancer Type in Survivors of Virus-Related and Non-Virus-Related Cancer Living With HIV in the French Dat’AIDS Cohort
por: Poizot-Martin, Isabelle, et al.
Publicado: (2021)

Prevalence and Spectrum of Second Primary Malignancies among People Living with HIV in the French Dat’AIDS Cohort
por: Poizot-Martin, Isabelle, et al.
Publicado: (2022)

Rapidly evolving conjunctivitis due to Pasteurella multocida, occurring after direct inoculation with animal droplets in an immuno-compromised host
por: Corchia, Anthony, et al.
Publicado: (2015)

Renal failure during chemotherapy: renal biopsy for assessing subacute nephrotoxicity of pemetrexed
por: Assayag, Maureen, et al.
Publicado: (2017)

Major Persistent 5′ Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues
por: Bouin, Alexis, et al.
Publicado: (2016)

Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort
por: Ghosn, Jade, et al.
Publicado: (2023)

Corticosteroid therapy for patients with COVID-19 pneumonia: a before–after study
por: Bani-Sadr, Firouzé, et al.
Publicado: (2020)

Pneumocystis jirovecii Pneumonia and Toxoplasmosis in PWH With HIV-Controlled Disease Treated for Solid Malignancies: A DAT’AIDS Study
por: Pansu, Nathalie, et al.
Publicado: (2022)

Regression Discontinuity for Causal Effect Estimation in Epidemiology
por: Oldenburg, Catherine E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tv6dr12n317sssh8shjk0t6n5n